SUPN CapEx to Revenue

Supernus Pharmaceuticals Inc · CapEx to Revenue

SUPN logo

SUPN CapEx to Revenue

Current (TTM)0.14%
SUPN CapEx/Revenue (25.09% → 0.14%)
High-resolution chart · PNG

SUPN capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Supernus Pharmaceuticals Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.1861%
0.1095%
0.0907%
0.0617%
0.3527%
0.6628%
0.6966%
0.2064%
0.6713%
0.7456%
1.4568%
0.4859%
19.5607%
50.8784%
85.3051%
277.3585%
1.8827%
1.5187%
25.095%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.